Patient Data Reporting White Papers & Articles

  1. What The Suvoda-Greenphire Merger Means For Clinical Trials 2/18/2026

    Simplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.

  2. Sponsor-Provided Source Templates: Your Questions Answered 2/6/2026

    See how centralized eSource improves trial operations through faster startup, better data quality, and real‑time protocol guidance. An expert Q&A offers practical tips for sponsors, sites, and CROs.

  3. Why Protocol‑Driven eSource Solves Data Capture For 80% Of Sites 2/6/2026

    Designing data capture around study protocols boosts data quality and real‑time visibility. Reducing transcription and aligning workflows helps teams improve compliance and speed decisions.

  4. Why The Everest Group Named Medable A Leader In eCOA 2/2/2026

    Discover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.

  5. Navigating The Post-Capture Era Of Clinical Trials 2/2/2026

    Liberating data through structured workflow management is the key to evolving clinical trials from a series of administrative hurdles into a high-speed engine for medical innovation.

  6. Improving The eCOA Experience 1/25/2026

    Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.

  7. The Value Of Patient-Reported Outcomes In Cancer Clinical Research 1/16/2026

    Standardizing patient-reported outcomes and real-time monitoring transforms the patient voice into a powerful tool for regulatory success and superior clinical care.

  8. Clinical Development Crystal Ball: What To Watch In 2026 1/16/2026

    Explore how AI integration, remote assessment, and precision measurement are reshaping clinical trials in 2026 to improve data quality and patient outcomes.

  9. Quantifying Potential: Leveraging Data To Showcase Biotech Value 1/14/2026

    Biotechs must use data-driven insights to prove asset potential. Real-world evidence and predictive analytics validate differentiation, forecast market opportunity, and build investor confidence.

  10. FDA Pushes For Patient Voice: ePRO In Oncology Trials 1/8/2026

    FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.